Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients.

MLA

Slevin, Amber R., et al. “Hepatitis C Virus Direct-Acting Antiviral Nonadherence: Relationship to Sustained Virologic Response and Identification of at-Risk Patients.” Journal of the American Pharmacists Association: JAPhA, vol. 59, no. 1, Jan. 2019, pp. 51–56. EBSCOhost, https://doi.org/10.1016/j.japh.2018.10.020.

APA

Slevin, A. R., Hart, M. J., Van Horn, C., Rahman, S., Samji, N. S., Szabo, A., Rein, L., Werner, S., & Saeian, K. (2019). Hepatitis C virus direct-acting antiviral nonadherence: Relationship to sustained virologic response and identification of at-risk patients. Journal of the American Pharmacists Association: JAPhA, 59(1), 51–56. https://doi.org/10.1016/j.japh.2018.10.020

Chicago

Slevin, Amber R., Mickey J. Hart, Caroline Van Horn, Syed Rahman, Naga Swetha Samji, Aniko Szabo, Lisa Rein, Shannon Werner, and Kia Saeian. 2019. “Hepatitis C Virus Direct-Acting Antiviral Nonadherence: Relationship to Sustained Virologic Response and Identification of at-Risk Patients.” Journal of the American Pharmacists Association: JAPhA 59 (1): 51–56. doi:10.1016/j.japh.2018.10.020.